BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11932895)

  • 1. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma.
    Shibao K; Izumi H; Nakayama Y; Ohta R; Nagata N; Nomoto M; Matsuo K; Yamada Y; Kitazato K; Itoh H; Kohno K
    Cancer; 2002 Apr; 94(7):1939-46. PubMed ID: 11932895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression pattern of UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 in early gastric carcinoma.
    Ishikawa M; Kitayama J; Nariko H; Kohno K; Nagawa H
    J Surg Oncol; 2004 Apr; 86(1):28-33. PubMed ID: 15048677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas.
    Yamamoto S; Nakamori S; Tsujie M; Takahashi Y; Nagano H; Dono K; Umeshita K; Sakon M; Tomita Y; Hoshida Y; Aozasa K; Kohno K; Monden M
    Pathobiology; 2004; 71(1):12-8. PubMed ID: 14555840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence.
    Gu C; Oyama T; Osaki T; Li J; Takenoyama M; Izumi H; Sugio K; Kohno K; Yasumoto K
    Br J Cancer; 2004 Jan; 90(2):436-42. PubMed ID: 14735190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression pattern of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetyl-galactosaminyl transferase-3 in squamous cell carcinoma of the esophagus.
    Ishikawa M; Kitayama J; Kohno K; Nagawa H
    Pathobiology; 2005; 72(3):139-45. PubMed ID: 15860931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma.
    Harada Y; Izumi H; Noguchi H; Kuma A; Kawatsu Y; Kimura T; Kitada S; Uramoto H; Wang KY; Sasaguri Y; Hijioka H; Miyawaki A; Oya R; Nakayama T; Kohno K; Yamada S
    Tumour Biol; 2016 Jan; 37(1):1357-68. PubMed ID: 26296622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines.
    Sutherlin ME; Nishimori I; Caffrey T; Bennett EP; Hassan H; Mandel U; Mack D; Iwamura T; Clausen H; Hollingsworth MA
    Cancer Res; 1997 Nov; 57(21):4744-8. PubMed ID: 9354435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinoma.
    Onitsuka K; Shibao K; Nakayama Y; Minagawa N; Hirata K; Izumi H; Matsuo K; Nagata N; Kitazato K; Kohno K; Itoh H
    Cancer Sci; 2003 Jan; 94(1):32-6. PubMed ID: 12708471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of GalNAc-T3 and its relationships with clinicopathological factors in 61 extrahepatic bile duct carcinomas analyzed using stepwise sections - special reference to its association with lymph node metastases-.
    Inoue T; Eguchi T; Oda Y; Nishiyama K; Fujii K; Izumi H; Kohno K; Yamaguchi K; Tanaka M; Tsuneyoshi M
    Mod Pathol; 2007 Feb; 20(2):267-76. PubMed ID: 17361208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
    Taniuchi K; Cerny RL; Tanouchi A; Kohno K; Kotani N; Honke K; Saibara T; Hollingsworth MA
    Oncogene; 2011 Dec; 30(49):4843-54. PubMed ID: 21625220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas.
    Kitada S; Yamada S; Kuma A; Ouchi S; Tasaki T; Nabeshima A; Noguchi H; Wang KY; Shimajiri S; Nakano R; Izumi H; Kohno K; Matsumoto T; Sasaguri Y
    Br J Cancer; 2013 Jul; 109(2):472-81. PubMed ID: 23799843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of polypeptide N-acetylgalactosaminyl transferase-3 and its association with clinicopathological factors in thyroid carcinomas.
    Mochizuki Y; Ito K; Izumi H; Kohno K; Amano J
    Thyroid; 2013 Dec; 23(12):1553-60. PubMed ID: 23659732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers.
    Dosaka-Akita H; Kinoshita I; Yamazaki K; Izumi H; Itoh T; Katoh H; Nishimura M; Matsuo K; Yamada Y; Kohno K
    Br J Cancer; 2002 Sep; 87(7):751-5. PubMed ID: 12232759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.
    Miyahara N; Shoda J; Kawamoto T; Furukawa M; Ueda T; Todoroki T; Tanaka N; Matsuo K; Yamada Y; Kohno K; Irimura T
    Clin Cancer Res; 2004 Mar; 10(6):2090-9. PubMed ID: 15041730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GalNAc-T3 and MUC1, a combined predictor of prognosis and recurrence in solitary pulmonary adenocarcinoma initially diagnosed as malignant solitary pulmonary nodule (≤ 3 cm).
    Xie Q; Li F; Zhao S; Guo T; Li Z; Fang L; Wang S; Liu W; Gu C
    Hum Cell; 2020 Oct; 33(4):1252-1263. PubMed ID: 32776306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.
    Wu C; Guo X; Wang W; Wang Y; Shan Y; Zhang B; Song W; Ma S; Ge J; Deng H; Zhu M
    BMC Cancer; 2010 Apr; 10():123. PubMed ID: 20356418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase isozymes T1 and T2 in human colorectal cancer.
    Kohsaki T; Nishimori I; Nakayama H; Miyazaki E; Enzan H; Nomoto M; Hollingsworth MA; Onishi S
    J Gastroenterol; 2000; 35(11):840-8. PubMed ID: 11085493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection.
    Li Z; Yamada S; Wu Y; Wang KY; Liu YP; Uramoto H; Kohno K; Sasaguri Y
    Oncotarget; 2016 Aug; 7(34):54463-54473. PubMed ID: 27276675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer.
    He H; Shen Z; Zhang H; Wang X; Tang Z; Xu J; Sun Y
    Br J Cancer; 2014 Apr; 110(8):2021-9. PubMed ID: 24619076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of prognostic parameters in colorectal carcinoma. I. Histopathological variability].
    Lanza G; Borghi L; Ballotta MR; Ferretti S; Morsiani E; Buccoliero F; Navarra G; Piva E; Facchini L; Cavazzini L
    Pathologica; 1992; 84(1090):131-53. PubMed ID: 1331943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.